Priapism: Reasons for failure by Frank Hinman Jr

Journal of Sexual Medicine

Volumn 4, Issue 6, 2007, Pages 1539-1543

  Glina, Sidney ^a   Burnett, Arthur L ^b   Becher, Edgardo ^c   Brock, Gerald ^d   Hellstrom, Wayne ^e  

^a Instituto H Ellis   (Brazil)

^b JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSIDAD DE BUENOS AIRES   (Argentina)

^d UNIVERSITY OF WESTERN ONTARIO   (Canada)

^e TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA ADRENERGIC RECEPTOR STIMULATING AGENT; ANTICOAGULANT AGENT; ESTROGEN; GANGLION BLOCKING AGENT; SEDATIVE AGENT;

ARTICLE; ASPIRATION; CLINICAL FEATURE; ERECTILE DYSFUNCTION; HUMAN; IMPOTENCE; INDUCED HYPOTHERMIA; NITROSATIVE STRESS; NONHUMAN; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PENILE FIBROSIS; PENIS ERECTION; PRIAPISM; PRIORITY JOURNAL; SEDATION; SURGICAL DRAINAGE; VEIN BLOOD FLOW; VENOUS STASIS;

EID: 35448968729     PISSN: 17436095     EISSN: 17436109     Source Type: Journal    
DOI: 10.1111/j.1743-6109.2007.00615.x     Document Type: Article

References (19)

1. Hinman F Jr. Priapism; Reasons for failure. J Urol 1960;83:420-8.
2. Burnett AL. Pathophysiology of priapism. Dysregulatory erection physiology thesis. J Urol 2003;170:26-34.
3. Lue TF, Hellstrom WJG, McAninch JW, Tanagho EA. Priapism: A refined approach to diagnosis and treatment. J Urol 1986;136:104-8.
4. Levine JF, Saenz de Tejada I, Payton TR, Goldstein I. Recurrent prolonged erections and priapism as a sequela of priapism: Pathophysiology and management. J Urol 1991;145:764-7.
5. Melman A, Serels S. Priapism. Int J Impot Res 2000;12:S133-9.
6. Champion HC, Bivalacqua TJ, Takimoto E, Kass DA, Burnett AL. Phosphodiesterase-5A dysregulation in penile erectile tissue is a mechanism of priapism. Proc Natl Acad Sci USA 2005;102:1661-6.
7. Bivalacqua TJ, Liu T, Musicki B, Champion HC, Burnett AL. Endothelial nitric oxide synthase keeps erection regulatory function balance in the penis. Eur Urol 2006 [Epub ahead of print].
8. Conti G. L'erection du penis humain et ses bases morphologicovasculaires. Acta Anat 1952;14:217.
9. Kiss F. Anatomisch-histologische Untersuchungen über die erection. Ztschr F.d. ges Anat 1921;61:455
10. Lue TF, Hellstrom WJG, McAnich JW. Priapism: A refined approach to diagnosis and treatment. J Urol 1986;136:104.
11. Bivalacqua TJ, Burnett AL. Priapism: New concepts in the pathophysiology and new treatment strategies. Curr Urol Rep 2006;7:497-502.
12. Burnett AL. Nitric oxide in the penis-science and therapeutic implications from erectile dysfunction to priapism. J Sex Med 2006;3:578-82.
13. Burnett AL, Bivalacqua TJ, Champion HC, Musicki B. Long-term oral phosphodiesterase 5 inhibitor therapy alleviates recurrent priapism. Urology 2006;67:1043-8.
14. Berger R, Billups K, Brock G, Broderick GA, Dhabuwala CB, Goldstein I, Hakim LS, Hellstrom W, Honig S, Levine LA, Lue T, Munarriz R, Montague DK, Mulcahy JJ, Nehra A, Rogers ZR, Rosen R, Seftel AD, Shabsigh R, Steers W. Report of the American Foundation for Urologic Disease (AFUD) Thought Leader Panel for evaluation and treatment of priapism. AFUD Thought Leader Panel on Evaluation and Treatment of Priapism. Int J Impot Res 2001;13(5 suppl):S39-43.
15. Pautler SE, Brock GB. Priapism. From Priapus to the present time. Urol Clin North Am 2001;28:391-403.
16. Chan PT, Bégin LR, Arnold D, Jacobson SA, Corcos J, Brock GB. Priapism secondary to penile metastasis: A report of two cases and a review of the literature. J Surg Oncol 1998;68:51-9.
17. Brock G, Breza J, Lue TF, Tanagho EA. High flow priapism: A spectrum of disease. J Urol 1993;150:968-71.
18. Hinman F. Priapism. Report of cases and a clinical study of literature with reference to its pathogenesis and surgical treatment. Ann Surg 1914;60:689.
19. Spycher MA, Hauri D. The ultrastructure of the erectile tissue in priapism. J Urol 1986;135:142-7.